Shimoda I, Koizumi M, Shimosegawa T, Shishido T, Ono T, Sato K, Ishizuka J, Toyota T
Third Department of Internal Medicine, Tohoku University School of Medicine, Sendai, Japan.
Pancreas. 1993 Mar;8(2):196-203. doi: 10.1097/00006676-199303000-00010.
The male WBN/Kob rats spontaneously develop diabetes mellitus with age. In this study, we examined how glucose tolerance, potency of insulin release, and histology of the pancreas were changed with age in this model. Furthermore, we examined the effect of FOY-305, a synthetic trypsin inhibitor, on this model. Male WBN/Kob rats were divided into two groups: one group fed on standard pellet diet (STD group) and the other on pellet containing 0.1% FOY-305 (FOY group) for 56 weeks after age 4 weeks. Oral glucose (2 g/kg) tolerance test, histology of the pancreas, and glucose (8.3 mM)- and arginine (10 mM)-stimulated insulin release from the isolated perfused pancreas were examined at 8, 20, 40, and 60 weeks of age in both groups. Pancreatic insulin content was examined at 60 weeks. In the STD group, impairment of glucose tolerance and destruction and fibrosis of pancreatic tissues progressed with age. Glucose-stimulated insulin release was remarkably reduced with age, while arginine-stimulated insulin release was preserved. By contrast, in the FOY group, development of glucose intolerance was delayed and the pancreas showed fewer pathologic changes compared with the STD group. Insulin releases in response to both glucose and arginine were preserved at all ages examined. Total pancreatic insulin content at 60 weeks of age was significantly greater than that of the STD group. The male WBN/Kob rat is a new type of diabetic model that shows a similar pattern of insulin release to that in rat with non-insulin-dependent diabetes mellitus and also shows unique histopathological changes in exocrine pancreas. FOY-305 was effective in preventing the development of diabetes in this model, although its mechanism is still unknown.
雄性WBN/Kob大鼠会随着年龄增长自发患上糖尿病。在本研究中,我们考察了该模型中葡萄糖耐量、胰岛素释放能力以及胰腺组织学随年龄的变化情况。此外,我们还研究了合成胰蛋白酶抑制剂FOY - 305对该模型的影响。4周龄后的雄性WBN/Kob大鼠被分为两组:一组喂食标准颗粒饲料(STD组),另一组喂食含0.1% FOY - 305的颗粒饲料(FOY组),持续56周。在两组大鼠8、20、40和60周龄时,分别进行口服葡萄糖(2 g/kg)耐量试验、胰腺组织学检查以及从离体灌注胰腺中检测葡萄糖(8.3 mM)和精氨酸(10 mM)刺激后的胰岛素释放情况。在60周龄时检测胰腺胰岛素含量。在STD组中,葡萄糖耐量受损以及胰腺组织的破坏和纤维化随年龄进展。葡萄糖刺激的胰岛素释放随年龄显著降低,而精氨酸刺激的胰岛素释放得以保留。相比之下,在FOY组中,葡萄糖不耐受的发展被延迟,与STD组相比,胰腺的病理变化较少。在所有检测的年龄阶段,对葡萄糖和精氨酸的胰岛素释放均得以保留。60周龄时胰腺总胰岛素含量显著高于STD组。雄性WBN/Kob大鼠是一种新型糖尿病模型,其胰岛素释放模式与非胰岛素依赖型糖尿病大鼠相似,并且在外分泌胰腺中也表现出独特的组织病理学变化。尽管FOY - 305的作用机制尚不清楚,但它在该模型中能有效预防糖尿病的发展。